- Home
- OMI vs XNCR Comparison
OMI vs XNCR Comparison
Compare OMI & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMI
- XNCR
- Stock Information
- Founded
- OMI 1882
- XNCR 1997
- Country
- OMI United States
- XNCR United States
- Employees
- OMI N/A
- XNCR N/A
- Industry
- OMI Medical Specialities
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- OMI Health Care
- XNCR Health Care
- Exchange
- OMI Nasdaq
- XNCR Nasdaq
- Market Cap
- OMI 545.4M
- XNCR 565.1M
- IPO Year
- OMI N/A
- XNCR 2013
- Fundamental
- Price
- OMI $7.10
- XNCR $7.23
- Analyst Decision
- OMI Hold
- XNCR Buy
- Analyst Count
- OMI 6
- XNCR 8
- Target Price
- OMI $12.67
- XNCR $26.43
- AVG Volume (30 Days)
- OMI 1.0M
- XNCR 623.7K
- Earning Date
- OMI 08-11-2025
- XNCR 08-06-2025
- Dividend Yield
- OMI N/A
- XNCR N/A
- EPS Growth
- OMI N/A
- XNCR N/A
- EPS
- OMI N/A
- XNCR N/A
- Revenue
- OMI $10,720,251,000.00
- XNCR $146,929,000.00
- Revenue This Year
- OMI $3.67
- XNCR N/A
- Revenue Next Year
- OMI $2.58
- XNCR $28.84
- P/E Ratio
- OMI N/A
- XNCR N/A
- Revenue Growth
- OMI 2.84
- XNCR N/A
- 52 Week Low
- OMI $6.07
- XNCR $7.07
- 52 Week High
- OMI $16.63
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- OMI 45.41
- XNCR 29.99
- Support Level
- OMI $6.30
- XNCR $7.07
- Resistance Level
- OMI $7.03
- XNCR $8.21
- Average True Range (ATR)
- OMI 0.43
- XNCR 0.54
- MACD
- OMI -0.10
- XNCR -0.20
- Stochastic Oscillator
- OMI 44.21
- XNCR 5.35
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.